Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ropinirole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103351325A details a selective borohydride reduction for Ropinirole intermediates, offering significant cost reduction in API manufacturing and enhanced supply reliability.
Novel 8-step route from phenylacetic acid. High purity, scalable, cost-effective manufacturing for Parkinson's treatment APIs.
Novel patent CN108440376A enables high-yield ropinirole hydrochloride production with simplified steps and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN112745256B reveals a novel non-Pd/C reduction route for Ropinirole intermediates. Achieve high purity and significant cost reduction in API manufacturing.